technology, Inc. Edmund Mickanas Advanced Cell VP of Regulatory technology, Inc. Ed Field Aldagen, Inc. President and CEO Robert Deans Athersys, Inc. Senior VP John Harrington Athersys, Inc. Executive Vice President and CSO Larry Couture Beckman Research Senior V.P., Sylvia R. and Isador Deutch Institute, City of Hope Center for Applied Technology Development and Prof. in Residence. Hans Kierstead CA Stem Cells Pratik Multani Fate Therapeutics Inc V.P., Clinical Development James Geraghty Genzyme Corporation Senior V.P. for Corporate Development, Product Acquisition and Partnering Transactions Michael Halpin Genzyme Corporation V.P., Regulatory Affairs Alison Lawton Genzyme Corporation Senior V.P., Global Market Access Tom Okarma Geron President and CEO Jane Lebkowski Geron Senior VP George Daley HHMI/ Children's Director, Stem Cell Transplantation Hospital Boston Program and Professor of Hematology Mahendra Rao Invitrogen Corporation V.P., Stem Cell Research John Walker iPierian Chief Executive Officer Leona Brenner-Gati Johnson and Johnson V.P., Science and Technology Mitch Finer Novocell Senior V.P., Development and Operations John West Novocell President and CEO Edward Baetge Novocell/ViaCyte VP and CSO Moya Daniles Osiris Senior Director, Regulatory Affairs/Quality Assurance Randy Mills Osiris President and CEO Michelle LeRoux Williams Osiris Chief Scientific Officer Erling Thor-Donnelly Pfizer, Inc. Associate Director, Worldwide Regulatory Strategy Mary Scott Pfizer, Inc. Director, Regulatory Affairs and Quality Assurance, Biotherapeutics and Bioinnovation Center Chaya Mazouz Pluristem, Inc VP Clinical and Regulatory Affairs Michael Hunt Reneuron CEO Rusty Gage Salk Institute Chair for Research on Age-Related Neurodegenerative Diseases Edward Lanphier Sangamo BioSciences, Founder, President and CEO Inc. Philip Gregory Chief Scientific Officer and Vice Sangamo BioSciences, Inc. President of Research Irv Weissman Stanford Director, Stem Cell Institute Stewart Craig Stem Cells Inc. Senior V.P., Development and Operations Ann Tsukomoto Stem Cells Inc. Executive V.P., Research and Development Michael Siani-Rose Theregen, Inc. President Gerhard Bauer UC Davis Fellow Recruit and Director of the Good Manufacturing Practice Laboratory Jan Nolta UC Davis Director, Stem Cell Research Program Donald Kohn UCLA Professor, Dep. Of Microbiology, Immunology and Molecular Genetics Antoni Ribas UCLA Associate Professor, Medical Oncology and Interest in Melanoma Owen Witte UCLA President, Developmental Immunology Dennis Carson UCSD Professor of Medicine and Director of Moores Cancer Center Jon Obermeyer Wake Forest Institute Director, External Education and for Regenerative Outreach Medicine Anthony Atala Wake Forest Institute Director, Institute for Regenerative for Regenerative Medicine Medicine Erik Forsberg WiCell Research Executive Director of Research Institute Institute